Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-14 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +27,500 27,500
2021-11-22 Ozeroff Christopher David S.V.P., General Counsel Purchase +50,000 $2.26 $113K 50,970
2020-12-21 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +55,000 55,000
2017-04-04 Ozeroff Christopher David S.V.P., General Counsel Sale −418 $2.41 $1K 17,517
2017-02-28 Ozeroff Christopher David S.V.P., General Counsel Sale −465 $2.61 $1K 17,935
2017-02-27 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +22,700 22,700
2017-02-16 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +24,000 24,000
2016-09-20 Ozeroff Christopher David S.V.P., General Counsel Sale −1,185 $2.89 $3K 18,400
2016-06-09 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +14,800 14,800
2016-06-09 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +30,200 30,200
2016-04-05 Ozeroff Christopher David S.V.P., General Counsel Sale −366 $3.52 $1K 19,585
2016-03-01 Ozeroff Christopher David S.V.P., General Counsel Sale −458 $3.51 $2K 19,951
2015-09-18 Ozeroff Christopher David S.V.P., General Counsel Sale −1,129 $6.32 $7K 20,409
2015-02-12 Ozeroff Christopher David S.V.P., General Counsel Grant or award +24,050 150,787
2015-02-12 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +12,950 12,950
2014-02-27 Ozeroff Christopher David S.V.P., General Counsel Grant or award +34,200 $1.95 $67K 126,737
2014-02-27 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +10,500 10,500
2013-09-17 Ozeroff Christopher David S.V.P., General Counsel Grant or award +75,000 $1.38 $104K 92,537
2013-09-17 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +42,642 42,642
2012-10-22 Ozeroff Christopher David SVP and General Counsel Grant or award +63,475 $0.39 $25K 105,233

Page 1 of 2 · 27 trades